Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Intangibles (2023 - 2025)

TransMedics has reported Intangibles over the past 3 years, most recently at $1.9 million for Q4 2025.

  • Quarterly results put Intangibles at $1.9 million for Q4 2025, down 9.48% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 9.48% YoY), and the annual figure for FY2025 was $1.9 million, down 9.48%.
  • Intangibles for Q4 2025 was $1.9 million at TransMedics, down from $2.0 million in the prior quarter.
  • Over the last five years, Intangibles for TMDX hit a ceiling of $2.4 million in Q3 2023 and a floor of $1.9 million in Q4 2025.
  • Median Intangibles over the past 3 years was $2.2 million (2024), compared with a mean of $2.2 million.
  • Biggest five-year swings in Intangibles: dropped 8.44% in 2024 and later fell 9.48% in 2025.
  • TransMedics' Intangibles stood at $2.4 million in 2023, then decreased by 8.58% to $2.2 million in 2024, then fell by 9.48% to $1.9 million in 2025.
  • The last three reported values for Intangibles were $1.9 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.